Revolutionary New Cancer Treatment Tested at Sheba Medical Center
An innovative, non-pharmaceutical treatment that filters the blood of cancer patients, similar to dialysis, is currently undergoing clinical trials at the Sheba Medical Center in Israel. Called immunopheresis, this revolutionary technology removes proteins produced by malignant cells that block the body's natural immune system, enabling the body to better attack and destroy cancerous tumor cells.
The 40-patient clinical study was conceived and led by Professor Gal Markel, director of the Ella Lemelbaum Institute for Immuno-Oncology at Sheba Medical Center. It will treat patients with various types of cancer, including breast cancer, resistant metastatic melanoma, renal cell carcinoma and lung cancer.
Professor Markel explained that certain cancer cells can protect themselves from the body's immune system by producing proteins that circulate in the patient's bloodstream and sabotage the ability of the immune cells to battle disease.
Prof. Markel added that the technology has the ability to "neutralize the cancer by filtering those proteins out of the bloodstream so that the patient's own immune system can fight effectively, either alone or in tandem with existing immunotherapy drugs." (INN / VFI News)